Jefferson Establishes New Center for Lung Cancer and Lung Disease

Contact:
Lee-Ann Landis
215-955-2240
Leeann.landis@jefferson.edu
 
 
Jefferson Establishes New Center for Lung Cancer and Lung Disease
 
(PHILADELPHIA) – Thomas Jefferson University and Hospitals announces the creation of the Jefferson - Jane and Leonard Korman Lung Center, made possible through major support from the Jane and Leonard Korman Family Foundation. The partnership will allow Jefferson to better understand lung disease through innovative research and expanded clinical programs for exceptional patient care. 
 
“Jane and I are pleased to be part of this new initiative which will not only save many lives through early detection and treatment, but also improve the quality of life for so many Jefferson patients. We look forward to seeing the Center have a positive impact in our community,” says Leonard Korman.
 
With its primary focus on lung cancer, the Center will attack the leading cause of cancer death in the United States and worldwide. Because lung cancer often progresses like a stealth disease, early diagnosis and improving treatment is of vital concern. 
 
“This investment enables us to recruit national leaders and further expand our clinical offerings to create a world class program for the treatment and prevention of lung disease, a group of acute and chronic conditions, including lung cancer, cystic fibrosis, emphysema, pneumonia and asthma,” says Gregory C. Kane, MD, Interim Chair of the Department of Medicine at Thomas Jefferson University Hospital.   
 
The Center will bring new power to bear against lung cancer, the cause of 570,000 deaths in the U.S. in 2011 and approximately 1.39 million worldwide. It, as well as several pulmonary diseases, is a deeply personal and life-altering disease for patients and their families. 
“Jefferson’s multidimensional programs in lung disease build on our knowledge of basic science,” says Mark L. Tykocinski, MD, The Anthony F. and Gertrude M. DePalma Dean, Jefferson Medical College; Senior Vice President, Thomas Jefferson University; and President, Jefferson University Physicians. “The Korman’s gift will allow us to reach the next level of research and position Jefferson to be a nationally recognized lung center with leading programs in personalized medicine and care for lung disease patients. We are incredibly grateful for their generosity.” 
 
 
 
The Korman’s gift makes possible the recruitment of three new faculty, the establishment of two clinical and research programs and an upgrade of current clinical and research facilities to build on Jefferson’s current national prominence in pulmonary and critical care medicine, currently ranked #12 in the nation by U.S. News & World Report. 
 
The Jefferson – Jane and Leonard Korman Lung Center
Innovative new therapies for early diagnosis of lung disease are beginning to change the landscape of the field and the expected disease trajectory for many of these patients. 
 
The Center’s priorities include expanding lung cancer care through development of a comprehensive program including evaluation and diagnosis through the lung cancer screening and nodule program, and growing surgical and oncologic care through partnerships with the departments of Surgery, Medical and Radiation Oncology. A lung cancer coordinator will be brought on to navigate patients through the program. 
 
The Korman’s support will allow for increased focus on basic and translational research through the recruitment of a lung biologist whose research is expected to enhance methods of detecting and treating a variety of lung diseases in the exam room. In addition, a medical oncologist will focus on bringing clinical trials and the newest advances in molecular therapeutics and personalized medicine to Jefferson patients.
 
The Institute will also focus on non-cancerous pulmonary disease care through the creation of the Asthma and Sarcoidosis Programs to improve outcomes for patients with asthma and sarcoidosis, a regionally prevalent disease that triggers the formation of non-cancerous masses in the lungs.  
Ongoing disease prevention and advanced pulmonary diagnostic programs will form the foundation of the program with the goal of disease prevention and halting lung disease before it develops.   
 
The Korman’s gift will also establish a fully-funded professorship in pulmonary medicine to enable Jefferson to continue the academic mission and research initiatives that characterize it as a leader in medical education and health care. 
 
About Jane and Leonard Korman and the Jane and Leonard Korman Family Foundation
The Jane and Leonard Korman family has long supported the efforts of Thomas Jefferson University and Hospitals.
 
Leonard I. Korman has been a Thomas Jefferson University trustee since 1998. He is Chairman and Chief Executive Officer of the Trevose, Pennsylvania-based real estate development and management company, Korman Commercial Properties, Inc. and a partner in the Korman Company. Mr. Korman has been engaged in all aspects of real estate management and development as owner and senior executive his entire adult life. 
 
Jane Korman has been a patron of the arts community for many years. Currently she is a Trustee of the Morris Arboretum of the University of Pennsylvania, a Trustee of the Museum of Arts and Design in New York and a member of the Board of Directors of the Philadelphia Craft Show. She is also a member of the Modern and Contemporary Art Committee and Women’s Committee of the Philadelphia Museum of Art.
 
Together, Jane and Leonard have been dedicated to creating and supporting numerous initiatives and programs in the cultural and healthcare fields throughout the region.   
# # #
 
About Thomas Jefferson University Hospitals
Thomas Jefferson University Hospitals (TJUH) are dedicated to excellence in patient care, patient safety and the quality of the healthcare experience. Consistently ranked by U.S. News & World Report among the nation's top hospitals, Thomas Jefferson University Hospital, established in 1825, has over 900 licensed acute care beds with major programs in a wide range of clinical specialties. TJUH is one of the few hospitals in the U.S. that is both a Level 1 Trauma Center and a federally-designated regional spinal cord injury center. TJUH patient care facilities include Jefferson Hospital for Neuroscience, the region’s only dedicated hospital for neuroscience, Methodist Hospital in South Philadelphia, and additional patient care facilities throughout Pennsylvania and New Jersey. TJUH partners with its education affiliate, Thomas Jefferson University.

Published: 12-13-2012

Close Window